Holen Sie sich die Stockscreener-App
20.10
1.77%
0.35
Vorhandelsmarkt:
19.98
-0.12
-0.60%
Schlusskurs vom Vortag:
$19.75
Offen:
$19.5
24-Stunden-Volumen:
1.10M
Relative Volume:
1.34
Marktkapitalisierung:
$1.67B
Einnahmen:
$1.94B
Nettoeinkommen (Verlust:
$109.92M
KGV:
15.62
EPS:
1.2867
Netto-Cashflow:
$226.99M
1W Leistung:
+2.71%
1M Leistung:
-3.78%
6M Leistung:
+18.44%
1J Leistung:
+37.30%
1-Tages-Spanne:
$19.06
$20.13
1-Wochen-Bereich:
$18.86
$20.13
52-Wochen-Spanne:
$11.84
$24.99
Pediatrix Medical Group Inc Stock (MD) Company Profile
Firmenname
Pediatrix Medical Group Inc
Sektor
Branche
Telefon
(954) 384-0175
Adresse
1301 CONCORD TERRACE, SUNRISE, FL
Compare MD vs HCA, THC, FMS, ENSG, UHS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MD
Pediatrix Medical Group Inc
|
20.10 | 1.64B | 1.94B | 109.92M | 226.99M | 1.2867 |
|
HCA
Hca Healthcare Inc
|
545.13 | 119.15B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
240.59 | 20.61B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.41 | 12.82B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
ENSG
Ensign Group Inc
|
209.97 | 12.04B | 4.11B | 239.98M | 193.10M | 4.12 |
|
UHS
Universal Health Services Inc
|
190.53 | 11.77B | 16.08B | 1.20B | 1.06B | 17.82 |
Pediatrix Medical Group Inc Stock (MD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-09-26 | Hochstufung | Jefferies | Hold → Buy |
| 2024-06-07 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-06-23 | Fortgesetzt | Stifel | Hold |
| 2020-10-19 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2020-01-03 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-12-12 | Hochstufung | Stifel | Hold → Buy |
| 2019-09-06 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-01-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Hold |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-09-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-09-18 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2018-08-03 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-07-12 | Eingeleitet | Leerink Partners | Mkt Perform |
| 2018-03-27 | Eingeleitet | Credit Suisse | Neutral |
| 2018-02-12 | Bestätigt | Mizuho | Neutral |
| 2017-12-13 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-09-18 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2017-05-30 | Bestätigt | Mizuho | Neutral |
| 2017-05-25 | Bestätigt | Stifel | Hold |
| 2017-05-04 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2017-03-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2017-03-10 | Herabstufung | JP Morgan | Overweight → Neutral |
Alle ansehen
Pediatrix Medical Group Inc Aktie (MD) Neueste Nachrichten
Aug Highlights: Is Pediatrix Medical Group Inc stock undervalued right nowMarket Movement Recap & Daily Profit Maximizing Tips - baoquankhu1.vn
Pediatrix Medical Group, Inc. $MD Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
Pediatrix’s Profit Return And Heavy Buybacks Could Be A Game Changer For Pediatrix Medical Group (MD) - Sahm
JPMorgan Chase & Co. Has $13.85 Million Holdings in Pediatrix Medical Group, Inc. $MD - MarketBeat
Pediatrix (NYSE: MD) EVP awarded stock; additional shares held in trust - Stock Titan
Pediatrix Medical Group (MD) CFO reports 3,676-share tax-withholding disposition - Stock Titan
A Look At Pediatrix Medical Group (MD) Valuation After Recent Share Price Weakness - Sahm
Pediatrix Medical Group, Inc. $MD Stock Position Reduced by Vanguard Group Inc. - MarketBeat
Pediatrix Medical Group, Inc. (MD) Stock Analysis: Exploring a 9% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Pediatrix Buybacks And Return To Profitability Recast Shareholder Prospects - Yahoo Finance
Is Pediatrix Medical Group (MD) Pricing Reflect Its DCF And P/E Valuation Gap - Yahoo Finance
Pediatrix anticipates $280M–$300M adjusted EBITDA in 2026 with focus on practice alignment and telemedicine - MSN
5 Insightful Analyst Questions From Pediatrix Medical Group's Q4 Earnings Call - Finviz
Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term - Yahoo Finance
Pediatrix Medical Group, Inc. Experiences Revision in Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
5 Insightful Analyst Questions From Pediatrix Medical Group’s Q4 Earnings Call - Yahoo Finance
Why Pediatrix Medical Group (MD) Stands Out as a Leading Long-Term Growth Stock - Bitget
MD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Pediatrix Medical Group, Inc. (MD) Stock Analysis: Exploring a Promising 8.92% Potential Upside - DirectorsTalk Interviews
UBS Adjusts Price Target on Pediatrix Medical to $22 From $23, Maintains Neutral Rating - marketscreener.com
Pediatrix Medical Group Q4 Earnings Call Highlights - MarketBeat
Pediatrix Medical Group Announces 47th Annual NEO: The Conference for Neonatology - The Joplin Globe
A Look At Pediatrix Medical Group (MD) Valuation After Mixed Q4 Results And Updated Guidance - Yahoo Finance
Hillsdale Investment Management Inc. Grows Stock Position in Pediatrix Medical Group, Inc. $MD - MarketBeat
Pediatrix (NYSE:MD) Slips on EPS Miss; NYSE Composite Reaction - Kalkine Media
Pediatrix Medical Group (NYSE:MD) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat
Pediatrix Medical Group Inc (MD) Shares Down 3.63% on Feb 20 - GuruFocus
Pediatrix Medical Group (MD) PT Lowered by Truist Securities | M - GuruFocus
Pediatrix Medical Q4 Earnings Miss Estimates Despite Declining Costs - TradingView
MD Q4 Deep Dive: Pricing and Payer Mix Resilience Offset Volume Weakness - Finviz
Pediatrix Medical Group, Inc. (NYSE:MD) Q4 2025 Earnings Call Transcript - Insider Monkey
Decoding Pediatrix Medical Group Inc (MD): A Strategic SWOT Insi - GuruFocus
Pediatrix Medical Earnings Call Highlights Steady Margin Focus - TipRanks
Why Pediatrix Medical Group Stock Tumbled on Thursday - The Motley Fool
Pediatrix Medical Group Inc (MD) Q4 2025 Earnings Call Highlights: Strong EBITDA Amid Revenue Challenges - GuruFocus
Truist Securities Adjusts Pediatrix Medical Price Target to $21 From $24, Maintains Hold Rating - marketscreener.com
Pediatrix Medical Group, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Pediatrix Medical Group Returns to Full-Year Profitability Following Practice Portfolio Realignment - AlphaStreet News
Pediatrix Medical Group (NYSE:MD) Shares Gap Down After Earnings Miss - MarketBeat
Pediatrix (MD) Q4 2025 Earnings Call Transcript - The Globe and Mail
Earnings call transcript: Pediatrix Medical misses Q4 2025 EPS, stock tumbles - Investing.com
Pediatrix Medical Group's (NYSE:MD) Q4 CY2025: Beats On Revenue - Finviz
Pediatrix Medical Group (MD) Q4 Earnings Lag Estimates - Yahoo Finance
Pediatrix Medical Group: Q4 Earnings Snapshot - kens5.com
Pediatrix Medical Group, Inc. SEC 10-K Report - TradingView
Pediatrix Medical (MD) Exceeds Q4 Revenue Expectations - GuruFocus
Pediatrix Medical (MD) Projects FY26 Adjusted EBITDA Between $28 - GuruFocus
Pediatrix Medical Group Reports Fourth Quarter Results - TradingView
Pediatrix Medical Group’s (NYSE:MD) Q4 CY2025: Beats On Revenue - Yahoo Finance
Pediatrix Medical Group shares rise despite earnings miss By Investing.com - Investing.com Canada
Finanzdaten der Pediatrix Medical Group Inc-Aktie (MD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.57%
1.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):